Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Real-time Estimate Tradegate  -  06:22 2022-09-30 am EDT
22.05 EUR   +3.89%
03:00aKKR, CVC weighing stakes in Spain's Quironsalud -El Confidencial
RE
09/28Europe's generic drugmakers say they may cut output due to energy bills
RE
09/28Europe's generic drugmakers may cut output due to surging energy bills
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société FRESENIUS SE & CO. KGAA
09/12Fresenius : Morgan Stanley – 20th Annual Global Healthcare Conference
PU
09/12Fresenius : 2023 DRG inflator for German hospitals set at 3.45 %
PU
09/07Benesch Healthcare+ Dialysis & Nephrology Digest No. 32
AQ
09/07Fresenius : Goldman Sachs – 19th Annual European Medtech and Healthcare Services Con..
PU
09/06Fresenius : Kabi receives U.S. FDA approval for biosimilar Stimufend®* (pegfilgrastim)
PU
09/05Fresenius : Commerzbank and ODDO BHF's annual Corporate Conference
PU
08/29Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
08/19Fresenius Se & Co. Kgaa : Michael Sen to succeed Stephan Sturm as CEO of Fresenius
EQ
08/09Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..
AQ
08/08Fresenius : Kabi introduces 2D barcodes in the US
PU
08/05Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
08/05Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
08/04Fresenius : Factsheet H1/22 (PDF)
PU
08/02Fresenius : Q2/2022 Key Figures (XLSX)
PU
08/02Fresenius : publishes financial results for the second quarter and first half of 2022 in l..
PU
08/02Fresenius : publishes financial results for the second quarter and first half of 2022 in l..
PU
08/02Fresenius : Medical Care publishes financial results for the second quarter and first half..
PU
08/01Fresenius : Kabi's regulatory submission for tocilizumab biosimilar accepted for review by..
PU
08/01Fresenius : Kabi completes acquisition of majority stake in mAbxience
PU
08/01Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
AQ
07/29Fresenius : Kabi launches IV Drug in the U.S.
PU
07/28Fresenius : Conference Call Preliminary Q2/2022 Results
PU
07/28Fresenius : Conference Call Presentation
PU
07/27Fresenius Se & Co. Kgaa : Significantly worsening headwinds at Fresenius Medical Care impa..
EQ
07/27Fresenius : Q2/H12022 Kennzahlen (PDF)
PU
07/18Fresenius : Kabi launches its first generic contrast media agent in the U.S.
PU
07/13Fresenius Kabi - Romidepsin for Injection Available from Fresenius Kabi
AQ
07/12Fresenius : Kabi launches IV Drug in the U.S.
PU
06/23Fresenius : JP Morgan European Healthcare Conference
PU
06/13Fresenius : Company Presentation
PU
06/10Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
06/10Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
06/07Fresenius : Acceptance rate for scrip dividend of Fresenius reaches 40%
PU
06/01Fresenius Kabi Introduces PEMEtrexed for Injection, USP in the U.S.
AQ
05/31Fresenius : Kabi launches IV Drug in the U.S.
PU
05/24Fresenius Kabi - EuroPN Study, New clinical data on medical nutrition therapy in critic..
AQ
05/20Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
05/19Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
05/06Fresenius : Quarterly Financial Report Q1/22
PU
05/05Fresenius with solid start to 2022 despite macroeconomic challenges
AQ
05/05Fresenius Kabi Completes Acquisition of Ivenix
AQ
05/03Fresenius : Kabi launches IV Cancer Drug in the U.S.
PU
05/03Fresenius : Kabi prolongs the production and supply contract with Cerus Corporation for an..
PU
05/03Fresenius : Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Freseniu..
PU
04/28Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection in Ready-to-Ad..
AQ
04/27Fresenius : Kabi launches Calcium Gluconate in freeflex® bags in the U.S.
PU
04/04Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
03/31Fresenius Kabi receives European Commission approval for its pegfilgrastim biosimilar S..
AQ
03/31Fresenius : 2021 TCFD Index (PDF, 119 KB)
PU
03/31Fresenius : Conference Call on the acquisition of Ivenix and majority stake in mAbxience (..
PU
03/31Fresenius : Kabi buys a majority stake in mAbxience and acquires Ivenix
PU
03/30Fresenius Se & Co. Kgaa : Announcement of the Convening of the General Meeting on May 13,..
EQ
03/30Fresenius : Kabi receives European Commission approval for its pegfilgrastim biosimilar St..
PU
03/25Fresenius Kabi Announces FDA Approval of SMOFlipid Lipid Injectable Emulsion for Pediat..
AQ
03/24Fresenius : Annual Report 2021 (IFRS) (PDF, 12.61 MB)
PU
03/24Fresenius : Participations in affiliated and associated companies (PDF, 0.77 MB)
PU
03/21Fresenius : Medical Care participates in three-way merger to create premier value-based ki..
PU
03/18Fresenius : nominates Dr. Christoph Zindel for Supervisory Board
PU
03/15Fresenius : Virtual Roadshow Nordics
PU
03/14Fresenius : Kabi receives regulatory clearance from the FDA for infusion pump system
PU
02/24Fresenius Se & Co. Kgaa : Notification and public disclosure of transactions by persons
EQ
02/22Fresenius : Conference Call FY 2021, Fresenius (PDF, 3.26 MB)
PU
02/14Fresenius : again has Germany's best online offering for job seekers, Potentialpark study ..
PU
01/17Fresenius Kabi is committed to achieving Net Zero emissions by 2045
AQ
01/10Fresenius : Helios acquires majority stake in U.S. fertility center
PU
01/04Fresenius : ODDO BHF Forum 2022
PU
01/03Fresenius : 40th Annual J.P. Morgan Healthcare Conference (PDF, 6.16 MB)
PU
01/03Fresenius : UniCredit Kepler Cheuvreux 21st German Corporate Conference (PDF, 6.16 MB)
PU
2021Fresenius : Kabi modernizes production facility in France
PU
2021Fresenius : again with top result in climate ranking
PU
2021Innovative EUR250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi
AQ
2021Fresenius : Medical Care's new FX CorAL dialyzer combines clinical performance with hemoco..
PU
2021Fresenius : Helios acquires oncological center and ophthalmic clinic in Colombia
PU
2021Fresenius : Jefferies Virtual London Healthcare Conference (PDF, 6.06 MB)
PU
2021Fresenius : again included in Dow Jones Sustainability Index
PU
1  2  3  4  5  6Next
Upcoming event on FRESENIUS SE & CO. KGAA